S&P ASX All Technology

3,964.00

0.35%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NTRP

NextTrip (NTRP)

NextTrip Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NTRP

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
13/11/2024	09:31	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NTRP	NextTrip Inc
13/11/2024	08:42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NTRP	NextTrip Inc
16/10/2024	07:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NTRP	NextTrip Inc
09/10/2024	07:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NTRP	NextTrip Inc
01/10/2024	20:43	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NTRP	NextTrip Inc
26/09/2024	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NTRP	NextTrip Inc
21/09/2024	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NTRP	NextTrip Inc
17/09/2024	07:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NTRP	NextTrip Inc
20/07/2024	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NTRP	NextTrip Inc
18/07/2024	23:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NTRP	NextTrip Inc
01/06/2024	06:25	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:NTRP	NextTrip Inc
05/02/2021	01:00	PR Newswire (US)	Synthetic Bryostatin Available to Expand Neurodegenerative Indication Trials	NASDAQ:NTRP	NextTrip Inc
03/12/2020	01:00	PR Newswire (US)	Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals	NASDAQ:NTRP	NextTrip Inc
03/12/2020	00:19	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
28/11/2020	09:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NTRP	NextTrip Inc
26/11/2020	09:15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NTRP	NextTrip Inc
25/11/2020	05:47	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NTRP	NextTrip Inc
25/11/2020	05:46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NTRP	NextTrip Inc
21/11/2020	01:13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NTRP	NextTrip Inc
21/11/2020	01:12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NTRP	NextTrip Inc
21/11/2020	01:00	PR Newswire (US)	Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates	NASDAQ:NTRP	NextTrip Inc
10/11/2020	09:02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NTRP	NextTrip Inc